Kinshasa, DR Congo / RankWire.AI / – The Democratic Republic of the Congo has confirmed that the total number of Ebola infections in its latest wave has reached 3,075, marking a significant increase following an unprecedented transmission surge. As reported by the health ministry, the outbreak has resulted in 1,354 deaths and 556 individuals have fully recovered. Currently, 755 patients are hospitalized or placed in specialized isolation units. Officially declared on May 15, this epidemic is the fastest-growing outbreak of Ebola on record, surpassing the 2,000-case mark on July 15 and adding another thousand cases in less than two weeks.
The outbreak is driven by the Bundibugyo strain of the Ebola virus, a rare variant for which no approved vaccines or specific antiviral treatments are currently available. On May 17, the World Health Organization announced a public health emergency of international concern, declaring the outbreak in the Democratic Republic of the Congo and neighboring Uganda. The risk of regional spread was deemed high due to cross-border movements and ongoing conflict within affected areas. Epidemiological data show that nearly 90 percent of confirmed cases are concentrated in the northeastern province of Ituri, which borders South Sudan and Uganda.
During a briefing on the emergency response, Dr. Jean Kaseya, Director General of the Africa Centres for Disease Control and Prevention, highlighted the dire situation faced by frontline health workers. He explained that shortages of specialized therapeutics, protective equipment, and international funding are causing preventable deaths. The current outbreak has claimed lives at a rate faster than the 2013 to 2016 West Africa epidemic, which resulted in over 11,000 deaths over two years. While previous outbreaks took about eight months to reach 1,000 fatalities, the current Bundibugyo strain surpassed that figure in just ten weeks.
Rising Cases and Regional Health Crisis
Efforts to contain the virus have been hampered by ongoing strikes by healthcare workers demanding unpaid wages, severely disrupting operations at several treatment centers. Officials from the DRC explained that, although diagnostic capabilities and field testing have improved, administrative delays and logistical issues are slowing containment measures. Healthcare staff in eastern provinces continue to protest for immediate disbursement of risk allowances and operational funds. Public health officials warn that ongoing labor strikes inside isolation facilities could accelerate community transmission in neighboring rural areas.
In light of the lack of approved targeted treatments, international research teams are fast-tracking clinical trials of candidate vaccines. Researchers from Oxford University announced that the first group of volunteers has received an experimental vaccine specifically designed to neutralize the Bundibugyo strain. Meanwhile, health authorities in neighboring East African countries have stepped up border screening and distributed protective gear at transit hubs. These governments are collaborating with international partners to prevent secondary transmission within major urban transit centers.
Confirmed Cases Surpass 3,000 as Outbreak Worsens
Epidemiological models reviewed by international agencies project that the outbreak could continue for several more months before peaking. International humanitarian organizations are organizing specialized medical airlifts to deliver diagnostic reagents, protective gear, and hydration fluids to affected hospitals. Experts emphasize that establishing reliable supply chains to remote treatment sites is crucial for reducing mortality. Community outreach programs are expanding to enhance contact tracing and address public skepticism around medical isolation procedures.
Global health organizations stress that controlling the epidemic requires continuous international financial backing and immediate supply of medical resources. The response plan prioritizes strengthening local healthcare capacity, ensuring health worker compensation, and deploying experimental vaccines under emergency use protocols. Authorities assert that swift deployment of therapeutics in combination with rigorous contact tracing is the most effective approach to halting regional transmission and safeguarding vulnerable populations across Central Africa.